Bank of New Hampshire’s Regeneron Pharmaceuticals REGN Stock Holding History

Bank of New Hampshire’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.48K	Sell	12 -12	-50%	-$8.17K	﹤0.01%	478
2026 Q1	$18.5K	Buy	+24	New	+$18.4K	﹤0.01%	408
2025 Q1	–	Sell	-2	Closed	-$1.43K	–	467
2024 Q4	$1.43K	Hold	2	–	–	﹤0.01%	446
2024 Q3	$2.1K	Hold	2	–	–	﹤0.01%	440
2024 Q2	$2.1K	Hold	2	–	–	﹤0.01%	462
2024 Q1	$1.93K	Hold	2	–	–	﹤0.01%	462
2023 Q4	$1.76K	Hold	2	–	–	﹤0.01%	454
2023 Q3	$1.65K	Hold	2	–	–	﹤0.01%	459
2023 Q2	$1.44K	Buy	+2	New	+$1.54K	﹤0.01%	476

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Bank of New Hampshire's REGN Position: Q2 2026 in Review

Bank of New Hampshire reduced its Regeneron Pharmaceuticals (REGN) stake by 50% in Q2 2026, selling an estimated $8.17K and leaving 12 shares worth $7.48K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

Bank of New Hampshire first reported a position in REGN in Q2 2023 and has held it in 9 quarters since. The position peaked at $18.5K in Q1 2026. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Bank of New Hampshire held 12 shares of Regeneron Pharmaceuticals worth $7.48K as of Q2 2026.
Bank of New Hampshire sold 12 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.17K.
Regeneron Pharmaceuticals made up ﹤0.01% of Bank of New Hampshire's portfolio in Q2 2026, its #478 holding.
Bank of New Hampshire first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 9 quarters since.
Bank of New Hampshire's Regeneron Pharmaceuticals position peaked at $18.5K in Q1 2026.
729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.